🇺🇸 FDA
Patent

US 7390813

Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents

granted A61KA61K31/496A61K31/551

Quick answer

US patent 7390813 (Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/496, A61K31/551